HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome.

AuthorsFrank Moosig, Wolfgang Ludwig Gross, Kristina Herrmann, Jan Phillip Bremer, Bernhard Hellmich
JournalAnnals of internal medicine (Ann Intern Med) Vol. 155 Issue 5 Pg. 341-3 (Sep 06 2011) ISSN: 1539-3704 [Electronic] United States
PMID21893636 (Publication Type: Clinical Trial, Phase II, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Immunologic Factors
  • Immunosuppressive Agents
  • Interleukin-5
  • mepolizumab
  • Methotrexate
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Churg-Strauss Syndrome (drug therapy, immunology)
  • Down-Regulation
  • Drug Therapy, Combination
  • Glucocorticoids (therapeutic use)
  • Humans
  • Immunologic Factors (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Interleukin-5 (immunology)
  • Methotrexate (therapeutic use)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: